Japan Ultrasound Devices Market Size

Japan Ultrasound Devices Market Analysis

The Japan Ultrasound Devices Market size is expected to grow from USD 447.22 million in 2023 to USD 600.75 million by 2028, at a CAGR of 6.08% during the forecast period (2023-2028).

COVID-19 had an adverse impact on the ultrasound devices market in Japan. An article titled "The Impact of COVID-19 on Surgical Procedures in Japan: Analysis of Data from the National Clinical Database" was published in the Springer Journal 2020. The rate of deterioration in surgery was just 10% to 15%. There was no discernible change in the number of pancreaticoduodenectomy and aortic replacement procedures conducted in 2020, despite a decline in the number of oncological and cardiovascular procedures performed that year. In addition, the number of cervical, breast, lung, and stomach screening operations fell by about 10% in May 2020 compared to the same month the previous year, reports the Japan Cancer Association (JCA). Additionally, somewhat fewer imaging studies were finished in April and May 2020. When suspected or confirmed patients are evaluated, medical professionals must wear disposal caps, glasses, medical masks, disposal protection clothes/impermeable isolation garments, hand gloves, and shoe covers to prevent the virus from spreading among the personnel. As a result, administrative costs in the Japanese healthcare industry have gone up. Thus, the market is expected to grow in the future.

With the rising disease burden, ultrasound devices are expected to grow over the forecast period of the study.  There are several players who are technologically advanced offering products in the market and consistently upgrading their technology. The article titled "National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis procedure" was published in the National Library of Medicine in 2020, At 4.4/100,000 (2900 deaths per year), cervical cancer mortality in Japan is higher than in other comparable high-income nations. This is due to very low cervical screening rates (below 30%) and vaccination rates (below levels that confer any population effect; 0.3% of the eligible population). The use of ultrasonography is becoming more popular across the nation as a result of its role in the early detection of cervical cancer. Consequently, it is anticipated that the ultrasound market would grow here. Furthermore, it is anticipated that the study market would rise as a result of technological developments in ultrasound technology and the introduction of new products by major regional players. For instance, Royal Philips introduced Lumify in June 2020, a high-quality handheld tele-ultrasound solution with Reacts that is currently on the market in Japan. The goal of Philips' tele-ultrasound solution is to make high-quality portable ultrasound available in Japan. It was introduced there with a novel subscription model that is exclusive to the sector. Thus, the abovementioned factors are expected to increase market growth.